Suppr超能文献

放射性导向手术术中使用 PET 探头定位肿瘤并验证分化型甲状腺癌的完全切除:一项初步研究。

Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study.

机构信息

Department of Surgery, Kyungpook National University, Daegu, Korea.

出版信息

Surgery. 2011 Mar;149(3):416-24. doi: 10.1016/j.surg.2010.08.004. Epub 2010 Oct 20.

Abstract

BACKGROUND

The major concerns in the surgical treatment of extensive or recurrent thyroid cancer include the difficulty of precise intraoperative and real-time tumor localization, the possibility of missing small metastatic lymph nodes during the operation, the need for reoperation due to recurrence, and complications. The usefulness and feasibility of an intraoperative PET probe have been reported for many other cancers; however, a standard, radioguided, operative protocol using a PET probe in thyroid cancer has not been established. The purpose of the current study was to evaluate the feasibility of an intraoperative PET probe with respect to precise tumor localization, verification of complete resection, and a decrease in unnecessary reoperations and complications.

METHODS

This was a prospective, controlled study. Inclusion criteria were thyroid cancer requiring a total thyroidectomy with a modified radical neck dissection (MRND) and recurrent thyroid cancer after thyroid surgery. The types of procedures included total thyroidectomy with MRND, selective neck dissection (SND), and excision of recurrent thyroid masses. The PET probe NodeSeeker(®) is a high-energy gamma probe seeking 511 keV photons. Operative exploration was carried out between 2 and 6 h after injection of (18)F-FDG. The surgeon calculated the target-to-background ratio (T/B ratio) by checking the 10-sec accumulated count using the PET probe. We performed a re-exploration if the T/B ratio was >1.3 in the operative bed.

RESULTS

Twelve patients underwent PET probe-guided operation. SNDs, mass excisions, total thyroidectomy with MRND, and MRND were performed on 7, 4, and 1 patient, respectively. All tumors were localized by the PET probe precisely in real time, and the lesions not observed on preoperative PET were detected by the PET probe in 7 patients. Furthermore, additional lymph nodes that were not identified on preoperative ultrasonography were detected in 1 patient. The mean T/B ratio of thyroid carcinoma was 1.51 ± 0.53 (range, 1.17-4.03) and the postoperative serum thyroglobulin off thyroid hormone was <2.0 ng/ml.

CONCLUSION

Radioguided surgery using an intraoperative PET probe in thyroid cancer appears to be a useful method for real-time tumor localization, verification of complete excision, and minimization of the possibility of residual cancer. Therefore, an intraoperative PET probe in thyroid cancer may decrease unnecessary reoperations and complications due to persistent disease.

摘要

背景

广泛或复发性甲状腺癌的外科治疗主要关注的问题包括术中精确和实时肿瘤定位的困难、手术过程中可能遗漏小的转移性淋巴结、因复发而需要再次手术的可能性,以及并发症。术中正电子发射断层扫描(PET)探头在许多其他癌症中的应用已经得到了证实;然而,尚未建立一种标准的、放射性导向的、使用 PET 探头的甲状腺癌手术操作方案。本研究旨在评估术中 PET 探头在精确肿瘤定位、验证完全切除、减少不必要的再次手术和并发症方面的可行性。

方法

这是一项前瞻性、对照研究。纳入标准为需要行甲状腺全切除术伴改良根治性颈淋巴结清扫术(MRND)的甲状腺癌和甲状腺手术后复发的甲状腺癌。手术类型包括甲状腺全切除术伴 MRND、选择性颈淋巴结清扫术(SND)和复发性甲状腺肿块切除术。PET 探头 NodeSeeker(®)是一种寻找 511keV 光子的高能伽马探头。在注射(18)F-FDG 后 2 至 6 小时进行手术探查。外科医生通过使用 PET 探头检查 10 秒累积计数来计算目标与背景的比值(T/B 比值)。如果手术床中的 T/B 比值>1.3,则进行再次探查。

结果

12 例患者接受了 PET 探头引导下的手术。7 例患者行 SND、肿块切除术、甲状腺全切除术伴 MRND 和 MRND,分别为 4 例和 1 例患者。所有肿瘤均被 PET 探头实时精确定位,7 例患者术前 PET 未观察到的病变也被 PET 探头检测到。此外,1 例患者术前超声检查未发现的额外淋巴结也被检测到。甲状腺癌的平均 T/B 比值为 1.51±0.53(范围 1.17-4.03),术后甲状腺球蛋白在甲状腺激素抑制下<2.0ng/ml。

结论

术中使用 PET 探头进行放射性导向手术似乎是一种实时肿瘤定位、验证完全切除和最小化残留癌可能性的有用方法。因此,甲状腺癌术中 PET 探头可能会减少因持续性疾病而导致的不必要的再次手术和并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验